Position in NVS
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$119,008,936
-$945,258,817 QoQ
Shares Held
759,373
-89.1% QoQ
Ownership
0.040%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
#30
of 1,603 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Dodge & Cox holds $7,907,700,561 across 13 Drug Manufacturers - General names. NVS ranks #5 (1.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | GILD |
Gilead Sciences, Inc.
|
23,677,567 | $2,991,423,814 | |
| 2 | GSK |
GSK plc
|
48,197,514 | $2,526,513,683 | |
| 3 | SNY |
Sanofi
|
28,088,274 | $1,198,245,768 | |
| 4 | NVO |
Novo Nordisk A S
|
20,397,110 | $977,837,453 | |
| 5 | NVS |
Novartis AG
This page
|
759,373 | $119,008,936 | |
| 6 | LLY |
ELI LILLY & Co
|
41,258 | $49,486,087 | |
| 7 | MRK |
Merck & Co., Inc.
|
135,750 | $17,443,875 | |
| 8 | AZN |
Astrazeneca PLC
|
55,949 | $10,609,049 |
All Filings in NVS
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $119,008,936 | 759,373 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $1,064,267,753 | 6,967,383 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $1,242,848,554 | 9,014,641 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $1,357,438,994 | 10,585,145 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $1,288,469,585 | 10,647,629 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $1,317,482,010 | 11,818,102 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $1,188,609,051 | 12,214,665 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $1,405,760,177 | 12,221,876 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $1,302,700,557 | 12,236,526 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $1,195,000,969 | 12,353,985 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $1,329,324,371 | 13,165,538 | Shares | Sole | 2024-02-22 | |
| 2023-09-30 | $1,656,673,551 | 16,264,221 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $1,655,641,772 | 16,407,113 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $1,868,766,560 | 20,312,680 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $1,882,564,467 | 20,751,372 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $1,599,908,418 | 21,048,657 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $1,906,385,563 | 22,552,769 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $2,443,329,339 | 27,844,209 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $2,470,987,263 | 28,249,540 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $2,393,365,302 | 29,265,900 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $2,231,115,898 | 24,453,265 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $1,852,371,858 | 21,670,237 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $2,041,180,088 | 21,615,801 | Shares | Sole | 2021-02-11 | |
| 2020-09-30 | $1,894,960,578 | 21,791,175 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $1,690,359,756 | 19,353,787 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $1,891,521,728 | 22,941,440 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||